APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Aprepitant

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Aprepitant Industry Growth and Trends Forecast to 2032

Report ID 173967030122 December 202598 pages

Choose your research edition.

Industry ResearchAprepitant Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Aprepitant Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Aprepitant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032188 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Aprepitant Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Aprepitant Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Aprepitant market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Aprepitant is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Aprepitant is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Aprepitant is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Aprepitant include Shanghai Yingrui Biomedical Technology Co., Ltd., Sandoz, Merck & Co., Vea Impex (I) Pvt. Ltd., Heron Therapeutics, Glenmark Pharmaceuticals, Aetos Pharma, Actiza Pharmaceutical and Aark Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Aprepitant market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Aprepitant market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Aprepitant market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Aprepitant.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Aprepitant market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Aprepitant Market by Company

Shanghai Yingrui Biomedical Technology Co., Ltd.

Sandoz

Merck & Co.

Vea Impex (I) Pvt. Ltd.

Heron Therapeutics

Glenmark Pharmaceuticals

Aetos Pharma

Actiza Pharmaceutical

Aark Pharmaceuticals

Aprepitant Segment by Type

Injection

Oral

Aprepitant Segment by Application

Hospital

Drug store

Aprepitant Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Aprepitant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Aprepitant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Aprepitant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Aprepitant manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Aprepitant in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Injection Table 2. Major Company of Oral Table 3. Global Aprepitant Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Aprepitant Sales by Type (2021-2026) & (k units) Table 5. Global Aprepitant Sales Market Share in Volume by Type (2021-2026) Table 6. Global Aprepitant Sales by Type (2021-2026) & (US$ Million) Table 7. Global Aprepitant Sales Market Share in Value by Type (2021-2026) Table 8. Global Aprepitant Price by Type (2021-2026) & (US$/unit) Table 9. Global Aprepitant Sales by Type (2027-2032) & (k units) Table 10. Global Aprepitant Sales Market Share in Volume by Type (2027-2032) Table 11. Global Aprepitant Sales by Type (2027-2032) & (US$ Million) Table 12. Global Aprepitant Sales Market Share in Value by Type (2027-2032) Table 13. Global Aprepitant Price by Type (2027-2032) & (US$/unit) Table 14. North America Aprepitant Sales by Type (2021-2026) & (k units) Table 15. North America Aprepitant Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Aprepitant Sales by Type (2021-2026) & (k units) Table 17. Europe Aprepitant Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Aprepitant Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Aprepitant Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Aprepitant Sales by Type (2021-2026) & (k units) Table 21. Latin America Aprepitant Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Aprepitant Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Aprepitant Sales by Type (2021-2026) & (US$ Million) Table 24. Aprepitant Industry Trends Table 25. Aprepitant Industry Drivers Table 26. Aprepitant Industry Opportunities and Challenges Table 27. Aprepitant Industry Restraints Table 28. Global Aprepitant Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Aprepitant Revenue Market Share by Company (2021-2026) Table 30. Global Aprepitant Sales by Company (2021-2026) & (k units) Table 31. Global Aprepitant Sales Share by Company (2021-2026) Table 32. Global Aprepitant Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Aprepitant Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Aprepitant Major Company Production Sites and Headquarters Table 35. Global Aprepitant Company, Product Type & Application Table 36. Global Aprepitant Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Aprepitant by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Aprepitant Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Aprepitant Sales by Region (2021-2026) & (k units) Table 41. Global Aprepitant Sales Market Share in Volume by Region (2021-2026) Table 42. Global Aprepitant Sales by Region (2021-2026) & (US$ Million) Table 43. Global Aprepitant Sales Market Share in Value by Region (2021-2026) Table 44. Global Aprepitant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Aprepitant Sales by Region (2027-2032) & (k units) Table 46. Global Aprepitant Sales Market Share in Volume by Region (2027-2032) Table 47. Global Aprepitant Sales by Region (2027-2032) & (US$ Million) Table 48. Global Aprepitant Sales Market Share in Value by Region (2027-2032) Table 49. Global Aprepitant Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Aprepitant Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Aprepitant Sales by Application (2021-2026) & (k units) Table 52. Global Aprepitant Sales Market Share in Volume by Application (2021-2026) Table 53. Global Aprepitant Sales by Application (2021-2026) & (US$ Million) Table 54. Global Aprepitant Sales Market Share in Value by Application (2021-2026) Table 55. Global Aprepitant Price by Application (2021-2026) & (US$/unit) Table 56. Global Aprepitant Sales by Application (2027-2032) & (k units) Table 57. Global Aprepitant Sales Market Share in Volume by Application (2027-2032) Table 58. Global Aprepitant Sales by Application (2027-2032) & (US$ Million) Table 59. Global Aprepitant Sales Market Share in Value by Application (2027-2032) Table 60. Global Aprepitant Price by Application (2027-2032) & (US$/unit) Table 61. North America Aprepitant Sales by Application (2021-2026) & (k units) Table 62. North America Aprepitant Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Aprepitant Sales by Application (2021-2026) & (k units) Table 64. Europe Aprepitant Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Aprepitant Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Aprepitant Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Aprepitant Sales by Application (2021-2026) & (k units) Table 68. Latin America Aprepitant Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Aprepitant Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Aprepitant Sales by Application (2021-2026) & (US$ Million) Table 71. Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information Table 72. Shanghai Yingrui Biomedical Technology Co., Ltd. Business Overview Table 73. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolio Table 75. Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Development Table 76. Sandoz Company Information Table 77. Sandoz Business Overview Table 78. Sandoz Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sandoz Aprepitant Product Portfolio Table 80. Sandoz Recent Development Table 81. Merck & Co. Company Information Table 82. Merck & Co. Business Overview Table 83. Merck & Co. Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Merck & Co. Aprepitant Product Portfolio Table 85. Merck & Co. Recent Development Table 86. Vea Impex (I) Pvt. Ltd. Company Information Table 87. Vea Impex (I) Pvt. Ltd. Business Overview Table 88. Vea Impex (I) Pvt. Ltd. Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolio Table 90. Vea Impex (I) Pvt. Ltd. Recent Development Table 91. Heron Therapeutics Company Information Table 92. Heron Therapeutics Business Overview Table 93. Heron Therapeutics Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Heron Therapeutics Aprepitant Product Portfolio Table 95. Heron Therapeutics Recent Development Table 96. Glenmark Pharmaceuticals Company Information Table 97. Glenmark Pharmaceuticals Business Overview Table 98. Glenmark Pharmaceuticals Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Glenmark Pharmaceuticals Aprepitant Product Portfolio Table 100. Glenmark Pharmaceuticals Recent Development Table 101. Aetos Pharma Company Information Table 102. Aetos Pharma Business Overview Table 103. Aetos Pharma Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. Aetos Pharma Aprepitant Product Portfolio Table 105. Aetos Pharma Recent Development Table 106. Actiza Pharmaceutical Company Information Table 107. Actiza Pharmaceutical Business Overview Table 108. Actiza Pharmaceutical Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Actiza Pharmaceutical Aprepitant Product Portfolio Table 110. Actiza Pharmaceutical Recent Development Table 111. Aark Pharmaceuticals Company Information Table 112. Aark Pharmaceuticals Business Overview Table 113. Aark Pharmaceuticals Aprepitant Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Aark Pharmaceuticals Aprepitant Product Portfolio Table 115. Aark Pharmaceuticals Recent Development Table 116. North America Aprepitant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 117. North America Aprepitant Sales by Country (2021-2026) & (k units) Table 118. North America Aprepitant Sales Market Share by Country (2021-2026) Table 119. North America Aprepitant Sales Forecast by Country (2027-2032) & (k units) Table 120. North America Aprepitant Sales Market Share Forecast by Country (2027-2032) Table 121. North America Aprepitant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. North America Aprepitant Market Size by Country (2021-2026) & (US$ Million) Table 123. North America Aprepitant Market Share by Country (2021-2026) Table 124. North America Aprepitant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. North America Aprepitant Market Share Forecast by Country (2027-2032) Table 126. Europe Aprepitant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 127. Europe Aprepitant Sales by Country (2021-2026) & (k units) Table 128. Europe Aprepitant Sales Market Share by Country (2021-2026) Table 129. Europe Aprepitant Sales Forecast by Country (2027-2032) & (k units) Table 130. Europe Aprepitant Sales Market Share Forecast by Country (2027-2032) Table 131. Europe Aprepitant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Europe Aprepitant Market Size by Country (2021-2026) & (US$ Million) Table 133. Europe Aprepitant Market Share by Country (2021-2026) Table 134. Europe Aprepitant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Europe Aprepitant Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Aprepitant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Aprepitant Sales by Country (2021-2026) & (k units) Table 138. Asia-Pacific Aprepitant Sales Market Share by Country (2021-2026) Table 139. Asia-Pacific Aprepitant Sales Forecast by Country (2027-2032) & (k units) Table 140. Asia-Pacific Aprepitant Sales Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Aprepitant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Aprepitant Market Size by Country (2021-2026) & (US$ Million) Table 143. Asia-Pacific Aprepitant Market Share by Country (2021-2026) Table 144. Asia-Pacific Aprepitant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 145. Asia-Pacific Aprepitant Market Share Forecast by Country (2027-2032) Table 146. Latin America Aprepitant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 147. Latin America Aprepitant Sales by Country (2021-2026) & (k units) Table 148. Latin America Aprepitant Sales Market Share by Country (2021-2026) Table 149. Latin America Aprepitant Sales Forecast by Country (2027-2032) & (k units) Table 150. Latin America Aprepitant Sales Market Share Forecast by Country (2027-2032) Table 151. Latin America Aprepitant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 152. Latin America Aprepitant Market Size by Country (2021-2026) & (US$ Million) Table 153. Latin America Aprepitant Market Share by Country (2021-2026) Table 154. Latin America Aprepitant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 155. Latin America Aprepitant Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Aprepitant Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Aprepitant Sales by Country (2021-2026) & (k units) Table 158. Middle East and Africa Aprepitant Sales Market Share by Country (2021-2026) Table 159. Middle East and Africa Aprepitant Sales Forecast by Country (2027-2032) & (k units) Table 160. Middle East and Africa Aprepitant Sales Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Aprepitant Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Aprepitant Market Size by Country (2021-2026) & (US$ Million) Table 163. Middle East and Africa Aprepitant Market Share by Country (2021-2026) Table 164. Middle East and Africa Aprepitant Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. Middle East and Africa Aprepitant Market Share Forecast by Country (2027-2032) Table 166. Key Raw Materials Table 167. Raw Materials Key Suppliers Table 168. Aprepitant Distributors List Table 169. Aprepitant Customers List Table 170. Research Programs/Design for This Report Table 171. Authors List of This Report Table 172. Secondary Sources Table 173. Primary Sources List of Figures Figure 1. Aprepitant Image Figure 2. Global Aprepitant Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Aprepitant Market Size (2021-2032) & (US$ Million) Figure 4. Global Aprepitant Sales (2021-2032) & (k units) Figure 5. Injection Image Figure 6. Global Injection Sales YoY Growth (2021-2032) & (k units) Figure 7. Oral Image Figure 8. Global Oral Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Aprepitant Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Aprepitant Market Share by Type 2025 VS 2032 Figure 11. North America Aprepitant Sales Market Share in Volume by Type in 2025 Figure 12. North America Aprepitant Sales Market Share in Value by Type in 2025 Figure 13. Europe Aprepitant Sales Market Share in Volume by Type in 2025 Figure 14. Europe Aprepitant Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Aprepitant Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Aprepitant Sales Market Share in Value by Type in 2025 Figure 17. Latin America Aprepitant Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Aprepitant Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Aprepitant Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Aprepitant Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Aprepitant Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Drug store Image Figure 26. Global Drug store Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Aprepitant Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Aprepitant Market Share by Application 2025 VS 2032 Figure 29. North America Aprepitant Sales Market Share in Volume by Application in 2025 Figure 30. North America Aprepitant Sales Market Share in Value by Application in 2025 Figure 31. Europe Aprepitant Sales Market Share in Volume by Application in 2025 Figure 32. Europe Aprepitant Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Aprepitant Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Aprepitant Sales Market Share in Value by Application in 2025 Figure 35. Latin America Aprepitant Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Aprepitant Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Aprepitant Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Aprepitant Sales Market Share in Value by Application in 2025 Figure 39. North America Aprepitant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Aprepitant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Aprepitant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Aprepitant Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Aprepitant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Aprepitant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Aprepitant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Aprepitant Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Aprepitant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Aprepitant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Aprepitant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Aprepitant Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Aprepitant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Aprepitant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Aprepitant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Aprepitant Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Aprepitant Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Aprepitant Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Aprepitant Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Aprepitant Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Aprepitant Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Aprepitant Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Injection
  • Oral
Applications
  • Hospital
  • Drug store
Companies covered
  • Shanghai Yingrui Biomedical Technology Co., Ltd.
  • Sandoz
  • Merck & Co.
  • Vea Impex (I) Pvt. Ltd.
  • Heron Therapeutics
  • Glenmark Pharmaceuticals
  • Aetos Pharma
  • Actiza Pharmaceutical
  • Aark Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Aprepitant Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Aprepitant Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Aprepitant Market by Type
  6. 1.3.1 Injection
  7. 1.3.2 Oral
  8. 1.4 Global Aprepitant Market Size by Type
  9. 1.4.1 Global Aprepitant Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Aprepitant Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Aprepitant Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Aprepitant Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Aprepitant Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Aprepitant Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Aprepitant Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Aprepitant Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Aprepitant Industry Trends
  2. 2.2 Aprepitant Industry Drivers
  3. 2.3 Aprepitant Industry Opportunities and Challenges
  4. 2.4 Aprepitant Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Aprepitant Revenue (2021-2026)
  2. 3.2 Global Top Players by Aprepitant Sales (2021-2026)
  3. 3.3 Global Top Players by Aprepitant Price (2021-2026)
  4. 3.4 Global Aprepitant Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Aprepitant Major Company Production Sites & Headquarters
  6. 3.6 Global Aprepitant Company, Product Type & Application
  7. 3.7 Global Aprepitant Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Aprepitant Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Aprepitant Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Aprepitant Tier 1, Tier 2, and Tier 3
4 Aprepitant Regional Status and Outlook
  1. 4.1 Global Aprepitant Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Aprepitant Historic Market Size by Region
  3. 4.2.1 Global Aprepitant Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Aprepitant Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Aprepitant Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Aprepitant Forecasted Market Size by Region
  7. 4.3.1 Global Aprepitant Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Aprepitant Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Aprepitant Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Aprepitant by Application
  1. 5.1 Aprepitant Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drug store
  4. 5.2 Global Aprepitant Market Size by Application
  5. 5.2.1 Global Aprepitant Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Aprepitant Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Aprepitant Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Aprepitant Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Aprepitant Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Aprepitant Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Aprepitant Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Aprepitant Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Shanghai Yingrui Biomedical Technology Co., Ltd.
  2. 6.1.1 Shanghai Yingrui Biomedical Technology Co., Ltd. Company Information
  3. 6.1.2 Shanghai Yingrui Biomedical Technology Co., Ltd. Business Overview
  4. 6.1.3 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Shanghai Yingrui Biomedical Technology Co., Ltd. Aprepitant Product Portfolio
  6. 6.1.5 Shanghai Yingrui Biomedical Technology Co., Ltd. Recent Developments
  7. 6.2 Sandoz
  8. 6.2.1 Sandoz Company Information
  9. 6.2.2 Sandoz Business Overview
  10. 6.2.3 Sandoz Aprepitant Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sandoz Aprepitant Product Portfolio
  12. 6.2.5 Sandoz Recent Developments
  13. 6.3 Merck & Co.
  14. 6.3.1 Merck & Co. Company Information
  15. 6.3.2 Merck & Co. Business Overview
  16. 6.3.3 Merck & Co. Aprepitant Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co. Aprepitant Product Portfolio
  18. 6.3.5 Merck & Co. Recent Developments
  19. 6.4 Vea Impex (I) Pvt. Ltd.
  20. 6.4.1 Vea Impex (I) Pvt. Ltd. Company Information
  21. 6.4.2 Vea Impex (I) Pvt. Ltd. Business Overview
  22. 6.4.3 Vea Impex (I) Pvt. Ltd. Aprepitant Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Vea Impex (I) Pvt. Ltd. Aprepitant Product Portfolio
  24. 6.4.5 Vea Impex (I) Pvt. Ltd. Recent Developments
  25. 6.5 Heron Therapeutics
  26. 6.5.1 Heron Therapeutics Company Information
  27. 6.5.2 Heron Therapeutics Business Overview
  28. 6.5.3 Heron Therapeutics Aprepitant Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Heron Therapeutics Aprepitant Product Portfolio
  30. 6.5.5 Heron Therapeutics Recent Developments
  31. 6.6 Glenmark Pharmaceuticals
  32. 6.6.1 Glenmark Pharmaceuticals Company Information
  33. 6.6.2 Glenmark Pharmaceuticals Business Overview
  34. 6.6.3 Glenmark Pharmaceuticals Aprepitant Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Glenmark Pharmaceuticals Aprepitant Product Portfolio
  36. 6.6.5 Glenmark Pharmaceuticals Recent Developments
  37. 6.7 Aetos Pharma
  38. 6.7.1 Aetos Pharma Company Information
  39. 6.7.2 Aetos Pharma Business Overview
  40. 6.7.3 Aetos Pharma Aprepitant Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Aetos Pharma Aprepitant Product Portfolio
  42. 6.7.5 Aetos Pharma Recent Developments
  43. 6.8 Actiza Pharmaceutical
  44. 6.8.1 Actiza Pharmaceutical Company Information
  45. 6.8.2 Actiza Pharmaceutical Business Overview
  46. 6.8.3 Actiza Pharmaceutical Aprepitant Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Actiza Pharmaceutical Aprepitant Product Portfolio
  48. 6.8.5 Actiza Pharmaceutical Recent Developments
  49. 6.9 Aark Pharmaceuticals
  50. 6.9.1 Aark Pharmaceuticals Company Information
  51. 6.9.2 Aark Pharmaceuticals Business Overview
  52. 6.9.3 Aark Pharmaceuticals Aprepitant Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Aark Pharmaceuticals Aprepitant Product Portfolio
  54. 6.9.5 Aark Pharmaceuticals Recent Developments
7 North America by Country
  1. 7.1 North America Aprepitant Sales by Country
  2. 7.1.1 North America Aprepitant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Aprepitant Sales by Country (2021-2026)
  4. 7.1.3 North America Aprepitant Sales Forecast by Country (2027-2032)
  5. 7.2 North America Aprepitant Market Size by Country
  6. 7.2.1 North America Aprepitant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Aprepitant Market Size by Country (2021-2026)
  8. 7.2.3 North America Aprepitant Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Aprepitant Sales by Country
  2. 8.1.1 Europe Aprepitant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Aprepitant Sales by Country (2021-2026)
  4. 8.1.3 Europe Aprepitant Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Aprepitant Market Size by Country
  6. 8.2.1 Europe Aprepitant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Aprepitant Market Size by Country (2021-2026)
  8. 8.2.3 Europe Aprepitant Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Aprepitant Sales by Country
  2. 9.1.1 Asia-Pacific Aprepitant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Aprepitant Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Aprepitant Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Aprepitant Market Size by Country
  6. 9.2.1 Asia-Pacific Aprepitant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Aprepitant Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Aprepitant Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Aprepitant Sales by Country
  2. 10.1.1 South America Aprepitant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Aprepitant Sales by Country (2021-2026)
  4. 10.1.3 South America Aprepitant Sales Forecast by Country (2027-2032)
  5. 10.2 South America Aprepitant Market Size by Country
  6. 10.2.1 South America Aprepitant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Aprepitant Market Size by Country (2021-2026)
  8. 10.2.3 South America Aprepitant Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Aprepitant Sales by Country
  2. 11.1.1 Middle East and Africa Aprepitant Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Aprepitant Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Aprepitant Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Aprepitant Market Size by Country
  6. 11.2.1 Middle East and Africa Aprepitant Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Aprepitant Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Aprepitant Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Aprepitant Value Chain Analysis
  2. 12.1.1 Aprepitant Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Aprepitant Production Mode & Process
  7. 12.2 Aprepitant Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Aprepitant Distributors
  10. 12.2.3 Aprepitant Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst